Meiotic recombination between highly similar duplicated sequences (nonallelic homologous recombination, NAHR) generates deletions, duplications, inversions and translocations, and it is responsible for genetic diseases known as 'genomic disorders', most of which are caused by altered copy number of dosage-sensitive genes. NAHR hot spots have been identified within some duplicated sequences. We have developed spermbased assays to measure the de novo rate of reciprocal deletions and duplications at four NAHR hot spots. We used these assays to dissect the relative rates of NAHR between different pairs of duplicated sequences. We show that (i) these NAHR hot spots are specific to meiosis, (ii) deletions are generated at a higher rate than their reciprocal duplications in the male germline and (iii) some of these genomic disorders are likely to have been underascertained clinically, most notably that resulting from the duplication of 7q11, the reciprocal of the deletion causing Williams-Beuren syndrome.
Meiotic recombination between highly similar duplicated sequences (nonallelic homologous recombination, NAHR) generates deletions, duplications, inversions and translocations, and it is responsible for genetic diseases known as 'genomic disorders', most of which are caused by altered copy number of dosage-sensitive genes. NAHR hot spots have been identified within some duplicated sequences. We have developed spermbased assays to measure the de novo rate of reciprocal deletions and duplications at four NAHR hot spots. We used these assays to dissect the relative rates of NAHR between different pairs of duplicated sequences. We show that (i) these NAHR hot spots are specific to meiosis, (ii) deletions are generated at a higher rate than their reciprocal duplications in the male germline and (iii) some of these genomic disorders are likely to have been underascertained clinically, most notably that resulting from the duplication of 7q11, the reciprocal of the deletion causing Williams-Beuren syndrome.
Genomic disorders are diseases caused by recurrent meiotic chromosomal rearrangements involving unstable genomic architectures 1 . Most frequently these involve nonallelic homologous recombination (NAHR) between highly similar duplicated sequences. NAHR between duplicated sequences in direct orientation results in deletion and duplication of intervening sequences, whereas NAHR between duplicated sequences in inverted orientation results in inversions. The predominant pathogenic mechanism for the genomic disorders associated with deletions and duplications is altered copy number of dosagesensitive genes 2 . In addition to its role in genomic disorders, NAHR is one of the major mechanisms contributing to nonpathogenic structural variation in the human genome 3 . The breakpoints of rearrangements caused by NAHR have been shown to cluster in defined hot spots within duplicated sequences, in a manner akin to that of allelic recombination hot spots 4 .
A simple model of NAHR suggests that recombination between duplicated sequences (paralogs) can take place in one of three ways: between paralogs on the same chromatid, between those on sister chromatids or between those on the homologous chromosome ( Fig. 1) . Only in the latter two cases are deletion and duplication reciprocal products of NAHR. According to this model of NAHR, the relative rates of deletion and duplication will be determined by the relative contribution that intrachromatid NAHR makes to the overall frequency of meiotic NAHR, and the rate of duplication (b + g) should never exceed the rate of deletion (a + b + g).
For several loci that undergo NAHR, there are known to be associated reciprocal deletion and duplication disorders, including hereditary neuropathy with liability to pressure palsies (HNPP, deletion) and Charcot-Marie-Tooth disease type 1A (CMT1A, duplication) 5 , Smith-Magenis syndrome (SMS) and Potocki-Lupski syndrome 6 , Prader-Willi syndrome/Angelman syndrome and 15q11q13 duplication 7 , velocardiofacial syndrome and dup22(q11.2q11.2) 8 , and Williams-Beuren syndrome (WBS) and dup7(q11.23) 9 . The rates at which these rearrangements occur during meiosis have been estimated from the prevalence of the resultant dominant disease phenotypes. However, not all NAHR-induced pathogenic deletions have yet been associated with pathogenic reciprocal duplications 1 . There are several possible explanations for this: a duplication might have a milder, diverse or negligible phenotypic impact 2 , which hinders clinical ascertainment; it might be embryonically lethal and thus never observed in the population; or it may simply occur much less frequently than its reciprocal deletion. To address this question by directly comparing rates of deletion and duplication, we developed breakpoint-specific real-time PCR assays to measure NAHR activity in the male germline at four known hot spots. These hot spots lie within the WBS low-copy repeats (LCRs) that sponsor the WBS deletion and dup7(q11.23) duplication 10 ; the AZFa human endogenous retroviruses (HERVs) that sponsor the AZFa deletion that causes male infertility and its reciprocal, apparently asymptomatic, duplication 11, 12 ; the CMT1A repeats (CMT1A-REPs) that sponsor the HNPP deletion and CMT1A duplication 13 ; and the LCR17p repeats that sponsor uncommon recurrent SMS deletions 14 (genomic regions are shown schematically in Supplementary  Fig. 1 online) .
Haplotyping pools of sperm genomes allows detailed investigation of allelic 15 and nonallelic 16 homologous recombination by permitting the analysis of large numbers of meioses. We adapted real-time PCR amplification of recombinant alleles 17 to measuring rates of NAHR. Applying nested breakpoint-specific PCR to pools of genomes from either blood or sperm, we determined the rates of meiotic and mitotic deletion and duplication at four NAHR hot spots (Fig. 2) . Each of the eight rearrangements was assayed in five unrelated sperm donors (Fig. 3) . We showed that all deletion and duplication events were specific to sperm. This observation affirms the specificity of our assay and the absence of mispriming and jumping PCR artifacts. Moreover, our rate estimate for duplication at the CMT1A-REP hot spot is in complete agreement with a previous sperm-based estimate for this rearrangement obtained by a different laboratory using a different assay 16 .
NAHR rates differed dramatically among the four hot spots, in ordinal agreement with rates estimated from disease prevalence. The lowest NAHR rate occurs between the repeats that are furthest apart, consistent with the hypothesis that the highest rates of NAHR occur at the closest repeats with the greatest homology 18 . However, NAHR rates at the CMT1A-REP hot spot are significantly (P ¼ 1 Â 10 -7 for deletions and P ¼ 0.003 for duplications, t-test) higher than those at the WBS-LCR hot spot, even though the latter hot spot is embedded in longer duplicated sequences sharing greater homology and similar separation between duplicated sequences at the two loci ( 
Figure 2 Assaying NAHR using real-time PCR. (a) Shown are two duplicated sequences that undergo NAHR (grey and black arrows). Circles above these arrows represent variant sites that distinguish these two highly similar sequences, and they flank a NAHR hot spot. Repeat-specific PCR primers target these sites in a nested fashion to amplify haplotypes of these sites that are diagnostic of deletions and duplications. This suggests that other factors, such as local recombinatorial activity, are also important in determining rates of NAHR 19 . We showed that both duplication and deletion occur at each hot spot, with deletion occurring at a higher rate ( Table 1) . We observed similar twofold ratios of deletion to duplication at the three autosomal NAHR hot spots and confirmed in control experiments that these differences cannot be attributed to differential amplification efficiency between deletion and duplication assays (Methods and Supplementary Fig. 2 online) .
Previous studies suggested variation in mutation rate between individuals, both for the WBS deletion 20 and CMT1A duplication 16 . We did not observe any substantial differences in NAHR rates among the five unrelated donors analyzed for each hot spot, although for some rearrangements, different individuals did seem to have subtle, but significant (non-overlapping 95% confidence intervals), differences in NAHR rates. We carried out genome-wide array-comparative genome hybridization (array-CGH) on eight of the nine sperm donors analyzed in this study to examine whether structural variation might account for these subtle differences in rate. We observed no large-scale structural variants in the regions assayed in these individuals ( Supplementary Fig. 3 online) .
By scaling for NAHR events outside of the assayed hot spot and for the ratio of paternal and maternal NAHR, we compared our estimated rates of de novo WBS deletions and CMT1A duplications with those estimated from disease prevalence. Scaling an averaged sperm-based estimate of the WBS deletion rate in this manner, we estimated a population prevalence of de novo rearrangements of 1/7,000 to 1/47,000 (Supplementary Note online); this range encompasses the disease-based estimates of the WBS deletion prevalence of 1/7,500 to 1/25,000 (ref. 10). Our averaged sperm-based estimates of the CMT1A duplication rate yielded a population prevalence of 1/23,000 to 1/79,000, which similarly encompasses the disease-based estimate of 1/23,000 to 1/41,000 (Supplementary Note).
We sequenced 96 breakpoints for each of the 8 rearrangements from a single sperm donor to confirm and fully characterize the breakpoint (Fig. 4) . These sequences confirm the recombinant nature of the amplified sequences and exclude the possibility that gene conversion of primer-binding sites could be contributing to our estimates of deletion and duplication. These breakpoint sequences showed NAHR activity profiles for each NAHR hot spot, the resolutions of which were governed by the location of paralogous sequence variants (PSVs) and varied between hot spots. At the CMT1A-REP hot spot, which has the most informative distribution of PSVs, NAHR was more frequent toward the center of each hot spot (Fig. 4) , as has been reported previously 16, 21 . Comparable profiles have been observed for reciprocal events at allelic homologous recombination hot spots 17, 22 . The NAHR profiles for reciprocal deletion and duplication events are highly similar at two hot spots (CMT1A REPs: P ¼ 0.09; LCR17p: P ¼ 0.11; Fisher's exact test) but differ significantly at the other two (AZFa HERV: P o 0.0001; WBS LCR: P o 0.001), which is suggestive of reciprocal crossover asymmetry due to unequal efficiencies of crossover initiation in the two paralogous sequences 23 . We observed short tracts of patchy gene conversion in 6 out of the 768 breakpoint sequences (Fig. 4 and Supplementary Table 1 online), 5 of which occurred at a common location in the CMT1A-REP hot spot, where gene conversion has previously been reported 16, 19 .
By comparing the rates of deletion and duplication, we can estimate the rate of intrachromatidal NAHR (a) and, by factoring in information from studies of affected individuals about the frequency with which de novo rearrangements are accompanied by the recombination of flanking markers, we can solve simultaneous equations to estimate rates of interchromatidal (b) and interchromosomal (g) NAHR (Supplementary Note). Intrachromatidal NAHR predominated at all NAHR hot spots, as evidenced by the more than twofold greater rate of deletions than duplications at every locus (a 4 b + g). For the Nine sperm donors (C, D, E, F, G, H, K, L and N) were studied overall, but for each pair of reciprocal deletion and duplication, the same five donors were assayed. Error bars represent 95% confidence limits for each rate estimate. For comparison with birth prevalence of the associated disorders, these NAHR rates need to be scaled to take account of NAHR events that occur outside the hot spot and sex biases in NAHR rates (Supplementary Note). 
L E T T E R S
CMT1A duplication, we estimated a, b and g to be 2.47 Â 10 À5 , 3.46 Â 10 À7 and 1.7 Â 10 À5 , respectively. In other words, the rate of interchromosomal NAHR (g) is estimated to be 50-fold higher than the rate of interchromatidal NAHR (b). Preliminary estimates for WBS deletions 10 also suggest that interchromatidal NAHR (b) at the WBS-LCR hot spot is much less frequent than either intrachromatidal (a) or interchromosomal (g) NAHR (Supplementary Note).
The frequency of intrachromosomal and interchromosomal NAHR at the CMT1A-REP hot spot can be estimated directly for one of our sperm donors by determining haplotypes of pairs of heterozygous SNPs in breakpoint sequences (Fig. 5) . Two of the four possible haplotypes would be generated by interchromatidal NAHR and the other two haplotypes by interchromosomal NAHR. We observed only the interchromosomal NAHR haplotypes among the 19 informative duplication breakpoint sequences (P o 0.0001; w-square test; null hypothesis of random haplotype formation), which corroborates our estimates of b and g above. By contrast, all four possible haplotypes of (different) informative SNPs were observed in informative breakpoint sequences of the reciprocal deletion. The absence of haplotype biases (P ¼ 0.23) confirms that interchromosomal (g) and intrachromosomal (a) deletion events occur at similar rates.
The rate of deletion relative to duplication (4.11:1) is highest at the haploid AZFa-HERV hot spot, which cannot undergo interchromosomal NAHR. Nevertheless, the relative rate of interchromatid NAHR is much higher than at the CMT1A-REP and WBS-LCR NAHR hot spots, which suggests that it might be suppressed at autosomal loci, although this hypothesis needs further testing across many loci.
In conclusion, sperm-based assays support the simple model for NAHR elaborated in Figure 1 and allow the relative contribution of different NAHR events to be dissected. Our results refute the common misconception that because deletion and duplication caused by NAHR can be reciprocal events, the rates are necessarily equal. The proportion of deletions to duplications in apparently healthy individuals is approximately equal in a recent survey of copy number variation 3 , which, given our finding that the rate of deletions caused by NAHR outstrips the rate of duplications by at least a factor of two, suggests either that other mechanisms generating copy number variation are biased toward duplications, or that selection removes deletions from the population more efficiently than duplications. These sperm-based assays are potentially of great value in guiding clinical diagnosis but will require precise knowledge of NAHR locations, so we encourage researchers to fine-map breakpoints of pathogenic rearrangements.
Our results have notable implications for clinical diagnosis of genomic disorders. First, we detected the reciprocal duplication for the LCR17p deletion 14 , which has not been previously reported. This LCR17p duplication should entirely encompass the duplication causing Potocki-Lupski syndrome, and so it should be expected that the larger duplication would also be characterized by developmental delay, cognitive impairment and autistic features 6, 24 . Second, the ratio at which the dominant disorders resulting from reciprocal deletion and duplication at the CMT1A REPs are diagnosed is 1:4 (J. Lupski, Baylor College of Medicine, personal communication). Our results suggest that this should be 2:1, and that HNPP, which confers a relatively mild and variable phenotype 25 , is being greatly underdiagnosed 26 . Third, there are several hundred WBS deletions reported in the literature 27 , but only four reciprocal duplications 9,28-30 . Our results suggest that the syndrome resulting from these duplications remains undiagnosed in the majority of cases. These observations argue strongly that the clinical application of methods that allow these genomic imbalances to be detected directly (for example, array-CGH) should be implemented more widely, so as to facilitate appropriate genetic counseling, improve diagnostic criteria and increase our understanding of genotype-phenotype relationships. Our findings underscore the rationale for pursuing similar detailed analyses for all genomic disorders, especially those at which interindividual variation in NAHR rates are suspected, such as Sotos syndrome. Moreover, we see great value in expanding these assays to include more donors (including individuals with genome instability disorders), tissues, species and loci, so as to characterize fully the genetic and environmental determinants of chromosomal rearrangement rates.
METHODS
Samples. Sperm samples were obtained from donors at the Bourn Hall IVF Clinic, and the Cambridge Local Research Ethics Committee (reference 04/ Q0108/46) approved their use for recombination analyses. We quantified DNA extracted from semen and blood (Supplementary Methods online) using a nanodrop spectrophotometer, and we used pulsed-field gel electrophoresis to monitor template length (data not shown).
Cloning and sequencing of donor sequences. We obtained reference alignments for duplicated sequences from the University of California Santa Cruz genome browser 31 . We designed PCR primers to amplify each hot spot and its flanking regions nonspecifically from all paralogs using Oligo6 (Molecular Biology Insights, Inc.) in conjunction with an oligonucleotide annealing temperature calculator (see URLs section below and Supplementary Table 2 online). We amplified loci from five sperm donors for all NAHR hot spots (Supplementary Table 3 online). These five sperm donors were drawn from a panel of nine sperm donors. The same sperm donors were used for deletion and duplication assays at each hot spot. We cloned paralogous sequences into MACH1 competent cells (Invitrogen) using the pGEM-T Easy Vector (Promega), reamplified DNA extracted from positive colonies and sequenced amplicons using v3.1 Big Dye Chemistry (Applied Biosystems).
Assay design. We manually aligned sequences of cloned hot spots using BioEdit (see URLs section below) and identified paralogous sequence variants for each locus. We designed nested paralog-specific primers as described above, so that the 3¢ nucleotide of each primer was specific for the paralog of interest, and we used additional internal mismatches when necessary (Supplementary Table 2 ). We tested primers for specificity on blood DNA using recombinant-specific combinations of primers. In addition, we designed a dual-labeled Q-PCR probe for each locus, to allow the second of the nested PCRs to be run on a real-time PCR machine (Applied Biosystems, 7500 unit; Supplementary Table 2) .
NAHR breakpoint detection and sequencing. We carried out primary paralog-specific PCRs in 1Â Platinum Taq buffer (Invitrogen) with 200 mM dNTPs (GE Healthcare), 300 nM of each primer, 1 unit Platinum Taq (Invitrogen), sufficient copies of template DNA to give approximately 24 positive wells per plate (exact quantities determined empirically) and 2-3 mM MgCl 2 (Supplementary Table 3 ), in a total volume of 50 ml. After thermal cycling, we incubated primary PCR products with 1 unit Escherichia coli Exonuclease I (NEB) for 1 h at 37 1C to digest primary primers, carried out a 20Â dilution using water and used 0.5 ml of diluted PCR product as a template in the secondary PCR. In the secondary PCR, we used identical concentrations of buffer, dNTPs, primers and enzyme as in the primary PCR, but the total volume was 25 ml, and we added a dual-labeled probe (final concentration 250 nM; Sigma) and 1Â Rox reference dye (Invitrogen) (Supplementary Table 3 ). We confirmed the reproducibility of the secondary PCR for a subset of plates by reamplifying the entire plate and showing 100% concordance with the wells containing breakpoint sequences (data not shown). To refine breakpoint locations, we reamplified wells that we had previously identified as positive from the primary PCR plate using secondary PCR primers and sequenced these amplicons.
Poisson correction of positive results and confidence limits. To account for the number of wells containing more than one identical recombinant template in the primary PCR, we carried out a Poisson correction on the observed number of positive reactions 15 . The Poisson corrected number of recombinants is given by -N ln[(N -R)/N], where N is the number of reactions performed and R is the number of positive reactions observed. The quantity of input sperm DNA was titrated to produce approximately 24 positive breakpointspecific amplifications per 96-well plate, thus increasing the probability that a positive result came from a single recombinant template molecule and keeping the increase in positive results after Poisson correction below 30% (ref. 15) . We calculated 95% confidence limits on the Poisson-corrected counts using the Epitools package in R.
Estimating amplification efficiency of duplications. To estimate the true amplification efficiency of our duplication assays, we generated a control recombinant duplication haplotype for each of the four NAHR hot spots by fusion PCR. This recombinant haplotype was cloned and sequenced to confirm its haplotype. This cloned haplotype was then used as a positive control template in the NAHR assays against a background of genomic DNA derived from blood. For each duplication assay, at least 192 reactions were carried out each with a 0.52 probability of containing a recombinant haplotype. We then counted, Poisson-corrected and calculated 95% confidence limits for the number of wells containing observed recombinant haplotypes. We then divided these values by the expected number of wells containing a recombinant Figure 5 Haplotypes of NAHR breakpoints at CMT1A REP. (a) The NAHR events leading to the four possible resultant SNP haplotypes in the breakpoint sequences for duplications at the CMT1A-REP hot spot are shown, classified into those that result in an exchange of flanking markers (interchromosomal) and those that do not (interchromatidal). The homologous chromosomes are indicated in red and blue. The phase of SNPs in CMT1A-REPs is inferred from the predominance of interchromosomal NAHR in affected individuals and from the inability of intramolecular NAHR to generate duplications. (b) The NAHR events leading to the four possible resultant SNP haplotypes in the breakpoint sequences for deletions at the CMT1A-REP hot spot are shown, classified into those that result in an exchange of flanking markers (interchromosomal) and those that do not (interchromatidal and intrachromatidal). The homologous chromosomes are indicated in red and blue.
